Patterns of p21waf1/cip1 expression in non-papillomatous nasal mucosa, endophytic sinonasal papillomas, and associated carcinomas

Journal of Clinical Pathology

Volumn 54, Issue 11, 2001, Pages 871-876

  Schwerer, M J ^a   Sailer, A ^a   Kraft, K ^a   Baczako, K ^b   Maier, H ^a  

^a Military Hospital Ulm   (Germany)

^b Institute of Pathology   (Germany)

Author keywords

Nasal mucosa; Sinonasal Papillomas; Squamous cell carcinomas

Indexed keywords

PROTEIN P21; PROTEIN P53;

ADOLESCENT; ADULT; AGED; ARTICLE; BASAL CELL; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COLUMNAR EPITHELIUM; CONTROLLED STUDY; CORRELATION FUNCTION; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; NOSE CARCINOMA; NOSE MUCOSA; NOSE POLYP; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; VIRUS INFECTION; WART VIRUS;

EID: 0035168922     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.54.11.871     Document Type: Article

References (48)

1. p21 is a universal inhibitor of cyclin kinases
2. WAF1, a potential mediator of p53 tumour suppression
3. p21/p53, cellular growth control and genomic integrity
4. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21
5. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
6. Involvement of the cell-cycle inhibitor Cip1/WAF1 and the EIA-associated p300 protein in terminal differentiation
7. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis
8. Absence of WAF1 mutations in a variety of human malignancies
9. A mutant p21 cyclin-dependent kinase inhibitor isolated from Burkitt's lymphoma
10. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas
11. Expression of p21/waf1 in oral squamous cell carcinomas - Correlation with p53 and mdm2 and cellular proliferation index
12. Inverting papillomas of the head and neck: The UCLA update
13. Inverted papilloma: A report of 112 cases
14. Inverted sinonasal papilloma. A molecular genetic appraisal of its putative status as a precursor to squamous cell carcinoma
15. Structural changes in the gastric foveolar epithelium in Helicobacter pylori-positive gastritis revealed by keratin immunohistochemistry
16. Antigen retrieval by microwave irradiation lowers immunohistological detection thresholds
17. The detection of human papillomaviruses in cervical biopsies by immunohistochemistry and in situ hybridization
18. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens
19. Assessment of p53 protein expression in normal mucosa and benign and malignant lesions of the nasal cavity
20. Induction of p21 (WAF1/CIP1) during differentiation
21. cip1 in muscle and other terminally differentiating cells
22. waf1 immunohistochemical expression in breast carcinoma: Correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival
23. p21/WAF1/CIP1 expression in normal mucosa, adenomas and adenocarcinomas of the colon: Its relationship with differentiation
24. waf1/cip1 in premalignant and malignant oral lesions: Relationship with p53 status
25. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues
26. Activities and response to DNA damage of latent and active sequence-specific DNA binding forms of mouse p53
27. Cleavage of CDK inhibitor p21 (Cip1/Waf1) by caspases is an early event during DNA damage-induced apoprosis
28. An immunohistochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping uing recombinant p53
29. p53 protein expression in benign lesions of the upper respiratory tract
30. Evaluation of anti-p53 antibody staining: Quality control and technical considerations
31. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx
32. p53 alteration and human papilloma virus infection in paranasal sinus cancer
33. Expression of p53 in normal nasal mucosa and in sinonasal papillomas with and without associated carcinoma and the relation to human papillomavirus (HPV)
34. Detection of human papillomavirus (HPV) in sinonasal inverted papillomas using polymerase chain reaction (PCR)
35. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous cell carcinoma
36. Identification of p53 and human papilloma virus in Schneiderian papillomas
37. Histogenesis of papillomas of the nose and paranasal sinuses
38. Inhibitory function of p21Cip1/WAF1 in differentiation of primary mouse keratinocytes independent of cell cycle control
39. WAF1 enhances papilloma formation but not malignant conversion in experimental mouse skin carcinogenesis
40. Posttranscriptional induction of p21cip1 protein in condylomata and dysplasias is inversely related to human papillomavirus activities
41. WAF1 and p53 expression in breast carcinoma: An immunohistochemical study in 261 patients with long-term follow-up
42. The expression of Waf1 in node-negative infiltrating ductal breast carcinoma
43. Mutations and defective expression of the WAF1/p21 tumour-suppressor gene in malignant melanomas
44. p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma
45. Transforming growth factor β induces cyclin-dependent kinase inhibitor p21 through p53-independent mechanism
46. Bcl-2 suppresses expression of p21WAF1/CIP1 in breast cancer cells
47. Concerted overexpression of the genes encoding p21 and cyclin D1 is associated with growth inhibition and differentiation in various carcinomas